Hasil Pencarian - Peter G. Rose

  • Menampilkan 1 - 15 hasil dari 15
Perbaiki Hasil
  1. 1
    Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report

    Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report oleh Peter G. Rose

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Prolonged treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing

    Prolonged treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing oleh Peter G. Rose

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30 days of surgery: A single institution review of 36 cases

    Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30 days of surgery: A single institution review of 36 cases oleh Laura J. Moulton, Peter G. Rose, Haider Mahdi

    Diterbitkan 2017-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series

    Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series oleh Peter G. Rose, Myra Feldman, Iwona Podzielinski, Aaron P. Petty, Roberto Vargas

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma

    Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma oleh Jonathan T. Hunt, Laura M. Chambers, Meng Yao, Amy Joehlin-Price, Robert Debernardo, Peter G. Rose

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population

    Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population oleh Michelle L. Kuznicki, Carrie Bennett, Meng Yao, Amy Joehlin-Price, Peter G. Rose, Haider Mahdi

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

    High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition oleh Ying Ni, Ahmed Soliman, Amy Joehlin-Price, Peter G. Rose, Anda Vlad, Robert P. Edwards, Haider Mahdi

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma

    Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma oleh Laura M. Chambers, Danielle Chau, Meng Yao, Anthony B. Costales, Peter G. Rose, Chad M. Michener, Robert Debernardo, Roberto Vargas

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Case Report: Circulating Tumor DNA Fraction Analysis Using Ultra-Low-Pass Whole-Genome Sequencing Correlates Response to Chemoradiation and Recurrence in Stage IV Small-Cell Carcinoma of the Cervix - A Longitudinal Study

    Case Report: Circulating Tumor DNA Fraction Analysis Using Ultra-Low-Pass Whole-Genome Sequencing Correlates Response to Chemoradiation and Recurrence in Stage IV Small-Cell Carcin... oleh Ata Abbas, Morgan Gruner, Jennifer Karohl, Peter G. Rose, Amy Joehlin-Price, Daniel Stover, Haider Mahdi, Haider Mahdi, Haider Mahdi

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer

    Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer oleh Laura M. Chambers, Meng Yao, Molly Morton, Morgan Gruner, Anna Chichura, Anthony B. Costales, Max Horowitz, Peter G. Rose, Chad M. Michener, Robert Debernardo

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

    Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer oleh Denise Uyar, Chad M. Michener, Erin Bishop, Elizabeth Hopp, Pippa Simpson, Liyun Zhang, Janet S. Rader, Peter G. Rose, Haider S. Mahdi, Robert Debernardo, Qiana Christian, William Bradley

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer

    LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer oleh Goutam Dey, Rashmi Bharti, Chad Braley, Ravi Alluri, Emily Esakov, Katie Crean-Tate, Keith McCrae, Amy Joehlin-Price, Peter G. Rose, Justin Lathia, Zihua Gong, Ofer Reizes

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer

    Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer oleh Elizabeth V. Connor, Caner Saygin, Chad Braley, Andrew C. Wiechert, Sheelarani Karunanithi, Katie Crean-Tate, Fadi W. Abdul-Karim, Chad M. Michener, Peter G. Rose, Justin D. Lathia, Ofer Reizes

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition

    Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition oleh Hussein Al-Sudani, Ying Ni, Philip Jones, Huseyin Karakilic, Lei Cui, Lisa D. S. Johnson, Peter G. Rose, Alexander Olawaiye, Robert P. Edwards, Robert A. Uger, Gloria H. Y. Lin, Haider Mahdi

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors

    Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors oleh Katie K. Crean-Tate, Chad Braley, Goutam Dey, Emily Esakov, Caner Saygin, Alexandria Trestan, Daniel J. Silver, Soumya M. Turaga, Elizabeth V. Connor, Robert DeBernardo, Chad M. Michener, Peter G. Rose, Justin Lathia, Ofer Reizes

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: